nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—breast cancer—Medroxyprogesterone Acetate—uterine cancer	0.247	1	CpDpCtD
Betamethasone—PGR—uterine cancer	0.128	0.593	CbGaD
Betamethasone—CYP19A1—uterine cancer	0.0879	0.407	CbGaD
Betamethasone—NR3C2—Progesterone—uterine cancer	0.0615	0.256	CbGbCtD
Betamethasone—PGR—Medroxyprogesterone Acetate—uterine cancer	0.06	0.25	CbGbCtD
Betamethasone—PGR—Progesterone—uterine cancer	0.0397	0.166	CbGbCtD
Betamethasone—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.0306	0.128	CbGbCtD
Betamethasone—Flurandrenolide—Medroxyprogesterone Acetate—uterine cancer	0.0236	0.113	CrCrCtD
Betamethasone—Prednicarbate—Medroxyprogesterone Acetate—uterine cancer	0.0207	0.0996	CrCrCtD
Betamethasone—NR3C1—Progesterone—uterine cancer	0.0203	0.0846	CbGbCtD
Betamethasone—Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.0191	0.0915	CrCrCtD
Betamethasone—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0186	0.0891	CrCrCtD
Betamethasone—Testolactone—Progesterone—uterine cancer	0.0181	0.0868	CrCrCtD
Betamethasone—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.0173	0.0828	CrCrCtD
Betamethasone—Fluoxymesterone—Progesterone—uterine cancer	0.0166	0.0798	CrCrCtD
Betamethasone—Fludrocortisone—Progesterone—uterine cancer	0.0162	0.0777	CrCrCtD
Betamethasone—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.0161	0.0774	CrCrCtD
Betamethasone—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0151	0.0727	CrCrCtD
Betamethasone—Prednisolone—Progesterone—uterine cancer	0.0138	0.066	CrCrCtD
Betamethasone—Hydrocortisone—Progesterone—uterine cancer	0.0132	0.0634	CrCrCtD
Betamethasone—PTGS2—Etoposide—uterine cancer	0.00641	0.0267	CbGbCtD
Betamethasone—ABCB1—Progesterone—uterine cancer	0.00473	0.0197	CbGbCtD
Betamethasone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00427	0.0178	CbGbCtD
Betamethasone—ABCB1—Dactinomycin—uterine cancer	0.00375	0.0156	CbGbCtD
Betamethasone—PGR—corpus luteum—uterine cancer	0.00364	0.137	CbGeAlD
Betamethasone—CYP19A1—corpus luteum—uterine cancer	0.00328	0.123	CbGeAlD
Betamethasone—CYP3A4—Progesterone—uterine cancer	0.00283	0.0118	CbGbCtD
Betamethasone—ABCB1—Etoposide—uterine cancer	0.00211	0.00882	CbGbCtD
Betamethasone—PLA2G1B—exocrine gland—uterine cancer	0.00157	0.0589	CbGeAlD
Betamethasone—CYP19A1—semen—uterine cancer	0.00154	0.0576	CbGeAlD
Betamethasone—ABCB1—Doxorubicin—uterine cancer	0.00144	0.00601	CbGbCtD
Betamethasone—CYP3A4—Etoposide—uterine cancer	0.00127	0.00528	CbGbCtD
Betamethasone—PGR—oviduct—uterine cancer	0.00125	0.047	CbGeAlD
Betamethasone—CYP3A4—Doxorubicin—uterine cancer	0.000864	0.0036	CbGbCtD
Betamethasone—PGR—artery—uterine cancer	0.000829	0.0311	CbGeAlD
Betamethasone—PLA2G1B—epithelium—uterine cancer	0.000683	0.0256	CbGeAlD
Betamethasone—PLA2G1B—renal system—uterine cancer	0.000634	0.0238	CbGeAlD
Betamethasone—PLA2G1B—female reproductive system—uterine cancer	0.000507	0.019	CbGeAlD
Betamethasone—PLA2G1B—female gonad—uterine cancer	0.000462	0.0173	CbGeAlD
Betamethasone—NR3C2—myometrium—uterine cancer	0.000431	0.0162	CbGeAlD
Betamethasone—PTGS2—artery—uterine cancer	0.000414	0.0155	CbGeAlD
Betamethasone—PGR—myometrium—uterine cancer	0.000401	0.015	CbGeAlD
Betamethasone—NR3C2—uterine cervix—uterine cancer	0.000335	0.0126	CbGeAlD
Betamethasone—NR3C2—smooth muscle tissue—uterine cancer	0.000326	0.0122	CbGeAlD
Betamethasone—PGR—epithelium—uterine cancer	0.000314	0.0118	CbGeAlD
Betamethasone—NR3C2—renal system—uterine cancer	0.000314	0.0118	CbGeAlD
Betamethasone—PGR—uterine cervix—uterine cancer	0.000312	0.0117	CbGeAlD
Betamethasone—NR3C2—endometrium—uterine cancer	0.000303	0.0114	CbGeAlD
Betamethasone—PGR—smooth muscle tissue—uterine cancer	0.000303	0.0114	CbGeAlD
Betamethasone—PGR—decidua—uterine cancer	0.000297	0.0111	CbGeAlD
Betamethasone—NR3C2—mammalian vulva—uterine cancer	0.000293	0.011	CbGeAlD
Betamethasone—PGR—endometrium—uterine cancer	0.000282	0.0106	CbGeAlD
Betamethasone—NR3C2—uterus—uterine cancer	0.00028	0.0105	CbGeAlD
Betamethasone—PGR—uterus—uterine cancer	0.00026	0.00975	CbGeAlD
Betamethasone—CYP19A1—endometrium—uterine cancer	0.000254	0.00952	CbGeAlD
Betamethasone—NR3C2—female reproductive system—uterine cancer	0.000251	0.00943	CbGeAlD
Betamethasone—CYP19A1—uterus—uterine cancer	0.000234	0.00877	CbGeAlD
Betamethasone—PGR—female reproductive system—uterine cancer	0.000234	0.00876	CbGeAlD
Betamethasone—NR3C1—myometrium—uterine cancer	0.000231	0.00867	CbGeAlD
Betamethasone—NR3C2—female gonad—uterine cancer	0.000229	0.00858	CbGeAlD
Betamethasone—NR3C2—vagina—uterine cancer	0.000227	0.00852	CbGeAlD
Betamethasone—Testolactone—CYP19A1—uterine cancer	0.000227	0.324	CrCbGaD
Betamethasone—PGR—female gonad—uterine cancer	0.000213	0.00797	CbGeAlD
Betamethasone—PGR—vagina—uterine cancer	0.000211	0.00792	CbGeAlD
Betamethasone—CYP19A1—female reproductive system—uterine cancer	0.00021	0.00788	CbGeAlD
Betamethasone—PTGS2—myometrium—uterine cancer	0.0002	0.0075	CbGeAlD
Betamethasone—CYP19A1—female gonad—uterine cancer	0.000191	0.00717	CbGeAlD
Betamethasone—NR3C1—epithelium—uterine cancer	0.000181	0.00681	CbGeAlD
Betamethasone—NR3C1—uterine cervix—uterine cancer	0.00018	0.00675	CbGeAlD
Betamethasone—NR3C1—smooth muscle tissue—uterine cancer	0.000175	0.00656	CbGeAlD
Betamethasone—NR3C1—decidua—uterine cancer	0.000171	0.00643	CbGeAlD
Betamethasone—NR3C1—renal system—uterine cancer	0.000168	0.00631	CbGeAlD
Betamethasone—NR3C1—endometrium—uterine cancer	0.000163	0.0061	CbGeAlD
Betamethasone—NR3C1—mammalian vulva—uterine cancer	0.000157	0.0059	CbGeAlD
Betamethasone—PTGS2—epithelium—uterine cancer	0.000157	0.00589	CbGeAlD
Betamethasone—PTGS2—uterine cervix—uterine cancer	0.000156	0.00584	CbGeAlD
Betamethasone—PTGS2—smooth muscle tissue—uterine cancer	0.000151	0.00568	CbGeAlD
Betamethasone—NR3C1—uterus—uterine cancer	0.00015	0.00562	CbGeAlD
Betamethasone—NR3C2—lymph node—uterine cancer	0.000147	0.00551	CbGeAlD
Betamethasone—PTGS2—renal system—uterine cancer	0.000146	0.00546	CbGeAlD
Betamethasone—Fluticasone Propionate—PGR—uterine cancer	0.000141	0.202	CrCbGaD
Betamethasone—PTGS2—endometrium—uterine cancer	0.000141	0.00528	CbGeAlD
Betamethasone—PGR—lymph node—uterine cancer	0.000137	0.00513	CbGeAlD
Betamethasone—NR3C1—female reproductive system—uterine cancer	0.000135	0.00506	CbGeAlD
Betamethasone—PTGS2—uterus—uterine cancer	0.00013	0.00487	CbGeAlD
Betamethasone—CYP3A4—renal system—uterine cancer	0.000127	0.00477	CbGeAlD
Betamethasone—ABCB1—myometrium—uterine cancer	0.000124	0.00464	CbGeAlD
Betamethasone—CYP19A1—lymph node—uterine cancer	0.000123	0.00461	CbGeAlD
Betamethasone—NR3C1—female gonad—uterine cancer	0.000123	0.0046	CbGeAlD
Betamethasone—NR3C1—vagina—uterine cancer	0.000122	0.00457	CbGeAlD
Betamethasone—PTGS2—female reproductive system—uterine cancer	0.000117	0.00438	CbGeAlD
Betamethasone—PTGS2—female gonad—uterine cancer	0.000106	0.00398	CbGeAlD
Betamethasone—PTGS2—vagina—uterine cancer	0.000106	0.00396	CbGeAlD
Betamethasone—Fluoxymesterone—ESR1—uterine cancer	0.000105	0.15	CrCbGaD
Betamethasone—CYP3A4—female reproductive system—uterine cancer	0.000102	0.00382	CbGeAlD
Betamethasone—Dexamethasone—CYP11A1—uterine cancer	0.0001	0.143	CrCbGaD
Betamethasone—ABCB1—epithelium—uterine cancer	9.71e-05	0.00364	CbGeAlD
Betamethasone—ABCB1—uterine cervix—uterine cancer	9.63e-05	0.00361	CbGeAlD
Betamethasone—ABCB1—decidua—uterine cancer	9.18e-05	0.00344	CbGeAlD
Betamethasone—ABCB1—renal system—uterine cancer	9.01e-05	0.00338	CbGeAlD
Betamethasone—ABCB1—endometrium—uterine cancer	8.71e-05	0.00327	CbGeAlD
Betamethasone—ABCB1—mammalian vulva—uterine cancer	8.43e-05	0.00316	CbGeAlD
Betamethasone—ABCB1—uterus—uterine cancer	8.03e-05	0.00301	CbGeAlD
Betamethasone—NR3C1—lymph node—uterine cancer	7.89e-05	0.00296	CbGeAlD
Betamethasone—Dexamethasone—PGR—uterine cancer	7.54e-05	0.108	CrCbGaD
Betamethasone—ABCB1—female reproductive system—uterine cancer	7.22e-05	0.00271	CbGeAlD
Betamethasone—PTGS2—lymph node—uterine cancer	6.82e-05	0.00256	CbGeAlD
Betamethasone—ABCB1—female gonad—uterine cancer	6.57e-05	0.00246	CbGeAlD
Betamethasone—ABCB1—vagina—uterine cancer	6.53e-05	0.00245	CbGeAlD
Betamethasone—Acute coronary syndrome—Etoposide—uterine cancer	6.03e-05	0.00129	CcSEcCtD
Betamethasone—Abdominal pain—Progesterone—uterine cancer	6.03e-05	0.00129	CcSEcCtD
Betamethasone—Body temperature increased—Progesterone—uterine cancer	6.03e-05	0.00129	CcSEcCtD
Betamethasone—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	6.01e-05	0.00129	CcSEcCtD
Betamethasone—Ulcer—Doxorubicin—uterine cancer	6e-05	0.00129	CcSEcCtD
Betamethasone—Myocardial infarction—Etoposide—uterine cancer	6e-05	0.00129	CcSEcCtD
Betamethasone—Neuropathy peripheral—Etoposide—uterine cancer	6e-05	0.00129	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	5.97e-05	0.00128	CcSEcCtD
Betamethasone—Fatigue—Medroxyprogesterone Acetate—uterine cancer	5.96e-05	0.00128	CcSEcCtD
Betamethasone—Malaise—Dactinomycin—uterine cancer	5.96e-05	0.00128	CcSEcCtD
Betamethasone—Skin exfoliation—Epirubicin—uterine cancer	5.85e-05	0.00125	CcSEcCtD
Betamethasone—Fluid retention—Epirubicin—uterine cancer	5.82e-05	0.00125	CcSEcCtD
Betamethasone—Neuropathy—Epirubicin—uterine cancer	5.76e-05	0.00123	CcSEcCtD
Betamethasone—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	5.7e-05	0.00122	CcSEcCtD
Betamethasone—Hiccups—Doxorubicin—uterine cancer	5.67e-05	0.00122	CcSEcCtD
Betamethasone—Dry eye—Epirubicin—uterine cancer	5.66e-05	0.00121	CcSEcCtD
Betamethasone—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	5.65e-05	0.00121	CcSEcCtD
Betamethasone—Myalgia—Dactinomycin—uterine cancer	5.62e-05	0.00121	CcSEcCtD
Betamethasone—Dermatitis contact—Doxorubicin—uterine cancer	5.61e-05	0.0012	CcSEcCtD
Betamethasone—Oesophagitis—Epirubicin—uterine cancer	5.6e-05	0.0012	CcSEcCtD
Betamethasone—Discomfort—Dactinomycin—uterine cancer	5.56e-05	0.00119	CcSEcCtD
Betamethasone—Ecchymosis—Epirubicin—uterine cancer	5.54e-05	0.00119	CcSEcCtD
Betamethasone—Urticaria—Medroxyprogesterone Acetate—uterine cancer	5.49e-05	0.00118	CcSEcCtD
Betamethasone—Asthenia—Progesterone—uterine cancer	5.47e-05	0.00117	CcSEcCtD
Betamethasone—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	5.46e-05	0.00117	CcSEcCtD
Betamethasone—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	5.46e-05	0.00117	CcSEcCtD
Betamethasone—Pulmonary oedema—Epirubicin—uterine cancer	5.46e-05	0.00117	CcSEcCtD
Betamethasone—Skin exfoliation—Doxorubicin—uterine cancer	5.42e-05	0.00116	CcSEcCtD
Betamethasone—Pruritus—Progesterone—uterine cancer	5.4e-05	0.00116	CcSEcCtD
Betamethasone—Oedema—Dactinomycin—uterine cancer	5.39e-05	0.00116	CcSEcCtD
Betamethasone—Fluid retention—Doxorubicin—uterine cancer	5.39e-05	0.00115	CcSEcCtD
Betamethasone—Infection—Dactinomycin—uterine cancer	5.36e-05	0.00115	CcSEcCtD
Betamethasone—Neuropathy—Doxorubicin—uterine cancer	5.33e-05	0.00114	CcSEcCtD
Betamethasone—Thrombocytopenia—Dactinomycin—uterine cancer	5.28e-05	0.00113	CcSEcCtD
Betamethasone—Dry eye—Doxorubicin—uterine cancer	5.24e-05	0.00112	CcSEcCtD
Betamethasone—Diarrhoea—Progesterone—uterine cancer	5.22e-05	0.00112	CcSEcCtD
Betamethasone—Oesophagitis—Doxorubicin—uterine cancer	5.18e-05	0.00111	CcSEcCtD
Betamethasone—Dexamethasone—CYP19A1—uterine cancer	5.17e-05	0.0739	CrCbGaD
Betamethasone—Thrombophlebitis—Epirubicin—uterine cancer	5.14e-05	0.0011	CcSEcCtD
Betamethasone—Anorexia—Dactinomycin—uterine cancer	5.14e-05	0.0011	CcSEcCtD
Betamethasone—Eye disorder—Etoposide—uterine cancer	5.13e-05	0.0011	CcSEcCtD
Betamethasone—Ecchymosis—Doxorubicin—uterine cancer	5.13e-05	0.0011	CcSEcCtD
Betamethasone—Diabetes mellitus—Epirubicin—uterine cancer	5.12e-05	0.0011	CcSEcCtD
Betamethasone—Pulmonary oedema—Doxorubicin—uterine cancer	5.05e-05	0.00108	CcSEcCtD
Betamethasone—Dizziness—Progesterone—uterine cancer	5.04e-05	0.00108	CcSEcCtD
Betamethasone—Angiopathy—Etoposide—uterine cancer	4.98e-05	0.00107	CcSEcCtD
Betamethasone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	4.96e-05	0.00106	CcSEcCtD
Betamethasone—Eye pain—Epirubicin—uterine cancer	4.93e-05	0.00106	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	4.91e-05	0.00105	CcSEcCtD
Betamethasone—Cardiac failure congestive—Epirubicin—uterine cancer	4.91e-05	0.00105	CcSEcCtD
Betamethasone—Pruritus—Medroxyprogesterone Acetate—uterine cancer	4.89e-05	0.00105	CcSEcCtD
Betamethasone—Alopecia—Etoposide—uterine cancer	4.85e-05	0.00104	CcSEcCtD
Betamethasone—Vomiting—Progesterone—uterine cancer	4.85e-05	0.00104	CcSEcCtD
Betamethasone—Rash—Progesterone—uterine cancer	4.81e-05	0.00103	CcSEcCtD
Betamethasone—Dermatitis—Progesterone—uterine cancer	4.8e-05	0.00103	CcSEcCtD
Betamethasone—Headache—Progesterone—uterine cancer	4.78e-05	0.00102	CcSEcCtD
Betamethasone—Thrombophlebitis—Doxorubicin—uterine cancer	4.76e-05	0.00102	CcSEcCtD
Betamethasone—Increased appetite—Epirubicin—uterine cancer	4.74e-05	0.00102	CcSEcCtD
Betamethasone—Diabetes mellitus—Doxorubicin—uterine cancer	4.73e-05	0.00101	CcSEcCtD
Betamethasone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	4.73e-05	0.00101	CcSEcCtD
Betamethasone—Decreased appetite—Dactinomycin—uterine cancer	4.69e-05	0.001	CcSEcCtD
Betamethasone—Dermatitis bullous—Epirubicin—uterine cancer	4.66e-05	0.000998	CcSEcCtD
Betamethasone—Fatigue—Dactinomycin—uterine cancer	4.65e-05	0.000997	CcSEcCtD
Betamethasone—Pain—Dactinomycin—uterine cancer	4.61e-05	0.000988	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Epirubicin—uterine cancer	4.6e-05	0.000986	CcSEcCtD
Betamethasone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	4.57e-05	0.00098	CcSEcCtD
Betamethasone—Eye pain—Doxorubicin—uterine cancer	4.56e-05	0.000978	CcSEcCtD
Betamethasone—Cardiac failure—Epirubicin—uterine cancer	4.56e-05	0.000978	CcSEcCtD
Betamethasone—Lethargy—Epirubicin—uterine cancer	4.54e-05	0.000974	CcSEcCtD
Betamethasone—Cardiac failure congestive—Doxorubicin—uterine cancer	4.54e-05	0.000973	CcSEcCtD
Betamethasone—Nausea—Progesterone—uterine cancer	4.53e-05	0.000971	CcSEcCtD
Betamethasone—Osteoarthritis—Epirubicin—uterine cancer	4.45e-05	0.000954	CcSEcCtD
Betamethasone—Feeling abnormal—Dactinomycin—uterine cancer	4.44e-05	0.000953	CcSEcCtD
Betamethasone—Ill-defined disorder—Etoposide—uterine cancer	4.44e-05	0.000951	CcSEcCtD
Betamethasone—Gastrointestinal pain—Dactinomycin—uterine cancer	4.41e-05	0.000945	CcSEcCtD
Betamethasone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	4.39e-05	0.000942	CcSEcCtD
Betamethasone—Increased appetite—Doxorubicin—uterine cancer	4.38e-05	0.00094	CcSEcCtD
Betamethasone—Affect lability—Epirubicin—uterine cancer	4.38e-05	0.000939	CcSEcCtD
Betamethasone—Migraine—Epirubicin—uterine cancer	4.38e-05	0.000939	CcSEcCtD
Betamethasone—Rash—Medroxyprogesterone Acetate—uterine cancer	4.36e-05	0.000934	CcSEcCtD
Betamethasone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	4.35e-05	0.000933	CcSEcCtD
Betamethasone—Headache—Medroxyprogesterone Acetate—uterine cancer	4.33e-05	0.000928	CcSEcCtD
Betamethasone—Malaise—Etoposide—uterine cancer	4.31e-05	0.000924	CcSEcCtD
Betamethasone—Dermatitis bullous—Doxorubicin—uterine cancer	4.31e-05	0.000924	CcSEcCtD
Betamethasone—Vertigo—Etoposide—uterine cancer	4.3e-05	0.000921	CcSEcCtD
Betamethasone—Abdominal pain—Dactinomycin—uterine cancer	4.26e-05	0.000914	CcSEcCtD
Betamethasone—Body temperature increased—Dactinomycin—uterine cancer	4.26e-05	0.000914	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Doxorubicin—uterine cancer	4.25e-05	0.000912	CcSEcCtD
Betamethasone—Cardiac arrest—Epirubicin—uterine cancer	4.23e-05	0.000907	CcSEcCtD
Betamethasone—ABCB1—lymph node—uterine cancer	4.22e-05	0.00158	CbGeAlD
Betamethasone—Cardiac failure—Doxorubicin—uterine cancer	4.22e-05	0.000905	CcSEcCtD
Betamethasone—Mood swings—Epirubicin—uterine cancer	4.22e-05	0.000904	CcSEcCtD
Betamethasone—Loss of consciousness—Etoposide—uterine cancer	4.2e-05	0.000901	CcSEcCtD
Betamethasone—Lethargy—Doxorubicin—uterine cancer	4.2e-05	0.000901	CcSEcCtD
Betamethasone—Convulsion—Etoposide—uterine cancer	4.14e-05	0.000888	CcSEcCtD
Betamethasone—Hypertension—Etoposide—uterine cancer	4.13e-05	0.000885	CcSEcCtD
Betamethasone—Osteoarthritis—Doxorubicin—uterine cancer	4.12e-05	0.000883	CcSEcCtD
Betamethasone—Nausea—Medroxyprogesterone Acetate—uterine cancer	4.11e-05	0.00088	CcSEcCtD
Betamethasone—Dry skin—Epirubicin—uterine cancer	4.08e-05	0.000875	CcSEcCtD
Betamethasone—Migraine—Doxorubicin—uterine cancer	4.05e-05	0.000869	CcSEcCtD
Betamethasone—Affect lability—Doxorubicin—uterine cancer	4.05e-05	0.000869	CcSEcCtD
Betamethasone—Hypokalaemia—Epirubicin—uterine cancer	4.05e-05	0.000868	CcSEcCtD
Betamethasone—Discomfort—Etoposide—uterine cancer	4.02e-05	0.000862	CcSEcCtD
Betamethasone—Muscular weakness—Epirubicin—uterine cancer	3.92e-05	0.000841	CcSEcCtD
Betamethasone—Cardiac arrest—Doxorubicin—uterine cancer	3.92e-05	0.000839	CcSEcCtD
Betamethasone—Anaphylactic shock—Etoposide—uterine cancer	3.9e-05	0.000837	CcSEcCtD
Betamethasone—Mood swings—Doxorubicin—uterine cancer	3.9e-05	0.000836	CcSEcCtD
Betamethasone—Infection—Etoposide—uterine cancer	3.88e-05	0.000831	CcSEcCtD
Betamethasone—Asthenia—Dactinomycin—uterine cancer	3.87e-05	0.000829	CcSEcCtD
Betamethasone—Thrombocytopenia—Etoposide—uterine cancer	3.82e-05	0.000819	CcSEcCtD
Betamethasone—Tachycardia—Etoposide—uterine cancer	3.81e-05	0.000816	CcSEcCtD
Betamethasone—Dry skin—Doxorubicin—uterine cancer	3.77e-05	0.000809	CcSEcCtD
Betamethasone—Hyperhidrosis—Etoposide—uterine cancer	3.77e-05	0.000809	CcSEcCtD
Betamethasone—Hypokalaemia—Doxorubicin—uterine cancer	3.75e-05	0.000803	CcSEcCtD
Betamethasone—Anorexia—Etoposide—uterine cancer	3.72e-05	0.000797	CcSEcCtD
Betamethasone—Diarrhoea—Dactinomycin—uterine cancer	3.69e-05	0.000791	CcSEcCtD
Betamethasone—Hypotension—Etoposide—uterine cancer	3.65e-05	0.000782	CcSEcCtD
Betamethasone—Muscular weakness—Doxorubicin—uterine cancer	3.63e-05	0.000779	CcSEcCtD
Betamethasone—Paraesthesia—Etoposide—uterine cancer	3.5e-05	0.000751	CcSEcCtD
Betamethasone—Weight increased—Epirubicin—uterine cancer	3.5e-05	0.00075	CcSEcCtD
Betamethasone—Weight decreased—Epirubicin—uterine cancer	3.48e-05	0.000746	CcSEcCtD
Betamethasone—Hyperglycaemia—Epirubicin—uterine cancer	3.47e-05	0.000744	CcSEcCtD
Betamethasone—Vomiting—Dactinomycin—uterine cancer	3.43e-05	0.000735	CcSEcCtD
Betamethasone—Rash—Dactinomycin—uterine cancer	3.4e-05	0.000729	CcSEcCtD
Betamethasone—Decreased appetite—Etoposide—uterine cancer	3.39e-05	0.000727	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Etoposide—uterine cancer	3.37e-05	0.000722	CcSEcCtD
Betamethasone—Fatigue—Etoposide—uterine cancer	3.36e-05	0.000721	CcSEcCtD
Betamethasone—Neuropathy peripheral—Epirubicin—uterine cancer	3.36e-05	0.000721	CcSEcCtD
Betamethasone—Pain—Etoposide—uterine cancer	3.34e-05	0.000715	CcSEcCtD
Betamethasone—Conjunctivitis—Epirubicin—uterine cancer	3.33e-05	0.000715	CcSEcCtD
Betamethasone—Weight increased—Doxorubicin—uterine cancer	3.24e-05	0.000694	CcSEcCtD
Betamethasone—Weight decreased—Doxorubicin—uterine cancer	3.22e-05	0.00069	CcSEcCtD
Betamethasone—Feeling abnormal—Etoposide—uterine cancer	3.22e-05	0.000689	CcSEcCtD
Betamethasone—Hyperglycaemia—Doxorubicin—uterine cancer	3.21e-05	0.000688	CcSEcCtD
Betamethasone—Nausea—Dactinomycin—uterine cancer	3.2e-05	0.000687	CcSEcCtD
Betamethasone—Gastrointestinal pain—Etoposide—uterine cancer	3.19e-05	0.000684	CcSEcCtD
Betamethasone—Bradycardia—Epirubicin—uterine cancer	3.13e-05	0.000672	CcSEcCtD
Betamethasone—Neuropathy peripheral—Doxorubicin—uterine cancer	3.11e-05	0.000667	CcSEcCtD
Betamethasone—Urticaria—Etoposide—uterine cancer	3.1e-05	0.000665	CcSEcCtD
Betamethasone—Haemoglobin—Epirubicin—uterine cancer	3.09e-05	0.000663	CcSEcCtD
Betamethasone—Abdominal pain—Etoposide—uterine cancer	3.08e-05	0.000661	CcSEcCtD
Betamethasone—Body temperature increased—Etoposide—uterine cancer	3.08e-05	0.000661	CcSEcCtD
Betamethasone—Conjunctivitis—Doxorubicin—uterine cancer	3.08e-05	0.000661	CcSEcCtD
Betamethasone—Haemorrhage—Epirubicin—uterine cancer	3.08e-05	0.00066	CcSEcCtD
Betamethasone—Visual impairment—Epirubicin—uterine cancer	2.97e-05	0.000636	CcSEcCtD
Betamethasone—Bradycardia—Doxorubicin—uterine cancer	2.9e-05	0.000622	CcSEcCtD
Betamethasone—Eye disorder—Epirubicin—uterine cancer	2.88e-05	0.000617	CcSEcCtD
Betamethasone—Haemoglobin—Doxorubicin—uterine cancer	2.86e-05	0.000614	CcSEcCtD
Betamethasone—Haemorrhage—Doxorubicin—uterine cancer	2.85e-05	0.000611	CcSEcCtD
Betamethasone—Asthenia—Etoposide—uterine cancer	2.8e-05	0.0006	CcSEcCtD
Betamethasone—Angiopathy—Epirubicin—uterine cancer	2.79e-05	0.000599	CcSEcCtD
Betamethasone—Pruritus—Etoposide—uterine cancer	2.76e-05	0.000592	CcSEcCtD
Betamethasone—Arrhythmia—Epirubicin—uterine cancer	2.75e-05	0.00059	CcSEcCtD
Betamethasone—Visual impairment—Doxorubicin—uterine cancer	2.75e-05	0.000589	CcSEcCtD
Betamethasone—Alopecia—Epirubicin—uterine cancer	2.72e-05	0.000583	CcSEcCtD
Betamethasone—Erythema—Epirubicin—uterine cancer	2.68e-05	0.000575	CcSEcCtD
Betamethasone—Diarrhoea—Etoposide—uterine cancer	2.67e-05	0.000572	CcSEcCtD
Betamethasone—Eye disorder—Doxorubicin—uterine cancer	2.66e-05	0.000571	CcSEcCtD
Betamethasone—Angiopathy—Doxorubicin—uterine cancer	2.58e-05	0.000554	CcSEcCtD
Betamethasone—Dizziness—Etoposide—uterine cancer	2.58e-05	0.000553	CcSEcCtD
Betamethasone—Arrhythmia—Doxorubicin—uterine cancer	2.54e-05	0.000546	CcSEcCtD
Betamethasone—Alopecia—Doxorubicin—uterine cancer	2.52e-05	0.00054	CcSEcCtD
Betamethasone—Ill-defined disorder—Epirubicin—uterine cancer	2.49e-05	0.000533	CcSEcCtD
Betamethasone—Vomiting—Etoposide—uterine cancer	2.48e-05	0.000532	CcSEcCtD
Betamethasone—Erythema—Doxorubicin—uterine cancer	2.48e-05	0.000532	CcSEcCtD
Betamethasone—Rash—Etoposide—uterine cancer	2.46e-05	0.000527	CcSEcCtD
Betamethasone—Dermatitis—Etoposide—uterine cancer	2.46e-05	0.000527	CcSEcCtD
Betamethasone—Headache—Etoposide—uterine cancer	2.44e-05	0.000524	CcSEcCtD
Betamethasone—Malaise—Epirubicin—uterine cancer	2.42e-05	0.000518	CcSEcCtD
Betamethasone—Vertigo—Epirubicin—uterine cancer	2.41e-05	0.000516	CcSEcCtD
Betamethasone—Syncope—Epirubicin—uterine cancer	2.4e-05	0.000515	CcSEcCtD
Betamethasone—Loss of consciousness—Epirubicin—uterine cancer	2.36e-05	0.000505	CcSEcCtD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	2.32e-05	0.00157	CbGpPWpGaD
Betamethasone—Convulsion—Epirubicin—uterine cancer	2.32e-05	0.000498	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.32e-05	0.00156	CbGpPWpGaD
Betamethasone—Nausea—Etoposide—uterine cancer	2.32e-05	0.000497	CcSEcCtD
Betamethasone—Hypertension—Epirubicin—uterine cancer	2.31e-05	0.000496	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—CYP11A1—uterine cancer	2.3e-05	0.00155	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—uterine cancer	2.3e-05	0.00155	CbGpPWpGaD
Betamethasone—Ill-defined disorder—Doxorubicin—uterine cancer	2.3e-05	0.000493	CcSEcCtD
Betamethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	2.29e-05	0.00154	CbGpPWpGaD
Betamethasone—Myalgia—Epirubicin—uterine cancer	2.28e-05	0.000489	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—NRAS—uterine cancer	2.27e-05	0.00153	CbGpPWpGaD
Betamethasone—Anxiety—Epirubicin—uterine cancer	2.27e-05	0.000487	CcSEcCtD
Betamethasone—PGR—Generic Transcription Pathway—CDKN2B—uterine cancer	2.26e-05	0.00153	CbGpPWpGaD
Betamethasone—Discomfort—Epirubicin—uterine cancer	2.25e-05	0.000483	CcSEcCtD
Betamethasone—Malaise—Doxorubicin—uterine cancer	2.24e-05	0.000479	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.23e-05	0.0015	CbGpPWpGaD
Betamethasone—Vertigo—Doxorubicin—uterine cancer	2.23e-05	0.000478	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.23e-05	0.0015	CbGpPWpGaD
Betamethasone—Syncope—Doxorubicin—uterine cancer	2.22e-05	0.000477	CcSEcCtD
Betamethasone—PTGS2—C-MYB transcription factor network—CDKN2A—uterine cancer	2.2e-05	0.00148	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—ESR2—uterine cancer	2.2e-05	0.00148	CbGpPWpGaD
Betamethasone—Anaphylactic shock—Epirubicin—uterine cancer	2.19e-05	0.000469	CcSEcCtD
Betamethasone—Oedema—Epirubicin—uterine cancer	2.19e-05	0.000469	CcSEcCtD
Betamethasone—Loss of consciousness—Doxorubicin—uterine cancer	2.18e-05	0.000467	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—AKR1C3—uterine cancer	2.18e-05	0.00147	CbGpPWpGaD
Betamethasone—Infection—Epirubicin—uterine cancer	2.17e-05	0.000466	CcSEcCtD
Betamethasone—Shock—Epirubicin—uterine cancer	2.15e-05	0.000461	CcSEcCtD
Betamethasone—Convulsion—Doxorubicin—uterine cancer	2.15e-05	0.000461	CcSEcCtD
Betamethasone—Nervous system disorder—Epirubicin—uterine cancer	2.14e-05	0.00046	CcSEcCtD
Betamethasone—Thrombocytopenia—Epirubicin—uterine cancer	2.14e-05	0.000459	CcSEcCtD
Betamethasone—Hypertension—Doxorubicin—uterine cancer	2.14e-05	0.000459	CcSEcCtD
Betamethasone—Tachycardia—Epirubicin—uterine cancer	2.13e-05	0.000458	CcSEcCtD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	2.13e-05	0.00143	CbGpPWpGaD
Betamethasone—Hyperhidrosis—Epirubicin—uterine cancer	2.11e-05	0.000453	CcSEcCtD
Betamethasone—Myalgia—Doxorubicin—uterine cancer	2.11e-05	0.000453	CcSEcCtD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.11e-05	0.00142	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.11e-05	0.00142	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—CHD4—uterine cancer	2.1e-05	0.00142	CbGpPWpGaD
Betamethasone—Anxiety—Doxorubicin—uterine cancer	2.1e-05	0.000451	CcSEcCtD
Betamethasone—Discomfort—Doxorubicin—uterine cancer	2.09e-05	0.000447	CcSEcCtD
Betamethasone—Anorexia—Epirubicin—uterine cancer	2.08e-05	0.000447	CcSEcCtD
Betamethasone—PGR—Generic Transcription Pathway—SMAD3—uterine cancer	2.07e-05	0.00139	CbGpPWpGaD
Betamethasone—Hypotension—Epirubicin—uterine cancer	2.04e-05	0.000438	CcSEcCtD
Betamethasone—Anaphylactic shock—Doxorubicin—uterine cancer	2.02e-05	0.000434	CcSEcCtD
Betamethasone—Oedema—Doxorubicin—uterine cancer	2.02e-05	0.000434	CcSEcCtD
Betamethasone—Infection—Doxorubicin—uterine cancer	2.01e-05	0.000431	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	1.99e-05	0.00135	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Epirubicin—uterine cancer	1.99e-05	0.000427	CcSEcCtD
Betamethasone—Shock—Doxorubicin—uterine cancer	1.99e-05	0.000427	CcSEcCtD
Betamethasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.99e-05	0.00134	CbGpPWpGaD
Betamethasone—Nervous system disorder—Doxorubicin—uterine cancer	1.98e-05	0.000426	CcSEcCtD
Betamethasone—Thrombocytopenia—Doxorubicin—uterine cancer	1.98e-05	0.000425	CcSEcCtD
Betamethasone—Insomnia—Epirubicin—uterine cancer	1.98e-05	0.000424	CcSEcCtD
Betamethasone—Tachycardia—Doxorubicin—uterine cancer	1.98e-05	0.000423	CcSEcCtD
Betamethasone—Paraesthesia—Epirubicin—uterine cancer	1.96e-05	0.000421	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—KRAS—uterine cancer	1.96e-05	0.00132	CbGpPWpGaD
Betamethasone—Hyperhidrosis—Doxorubicin—uterine cancer	1.96e-05	0.000419	CcSEcCtD
Betamethasone—PTGS2—C-MYB transcription factor network—CDKN1B—uterine cancer	1.95e-05	0.00131	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SRD5A2—uterine cancer	1.95e-05	0.00131	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NDUFB11—uterine cancer	1.95e-05	0.00131	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKR1B10—uterine cancer	1.93e-05	0.0013	CbGpPWpGaD
Betamethasone—Anorexia—Doxorubicin—uterine cancer	1.93e-05	0.000414	CcSEcCtD
Betamethasone—Dyspepsia—Epirubicin—uterine cancer	1.93e-05	0.000413	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—CCL2—uterine cancer	1.92e-05	0.0013	CbGpPWpGaD
Betamethasone—Decreased appetite—Epirubicin—uterine cancer	1.9e-05	0.000408	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	1.9e-05	0.00128	CbGpPWpGaD
Betamethasone—Hypotension—Doxorubicin—uterine cancer	1.89e-05	0.000405	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.89e-05	0.00127	CbGpPWpGaD
Betamethasone—Gastrointestinal disorder—Epirubicin—uterine cancer	1.89e-05	0.000405	CcSEcCtD
Betamethasone—Fatigue—Epirubicin—uterine cancer	1.89e-05	0.000404	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	1.87e-05	0.00126	CbGpPWpGaD
Betamethasone—Pain—Epirubicin—uterine cancer	1.87e-05	0.000401	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—TP53—uterine cancer	1.87e-05	0.00126	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	1.84e-05	0.000395	CcSEcCtD
Betamethasone—Insomnia—Doxorubicin—uterine cancer	1.83e-05	0.000392	CcSEcCtD
Betamethasone—NR3C1—Generic Transcription Pathway—PGR—uterine cancer	1.82e-05	0.00123	CbGpPWpGaD
Betamethasone—Paraesthesia—Doxorubicin—uterine cancer	1.82e-05	0.00039	CcSEcCtD
Betamethasone—Feeling abnormal—Epirubicin—uterine cancer	1.8e-05	0.000386	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—PIK3CA—uterine cancer	1.8e-05	0.00121	CbGpPWpGaD
Betamethasone—Gastrointestinal pain—Epirubicin—uterine cancer	1.79e-05	0.000383	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—CDKN2B—uterine cancer	1.79e-05	0.00121	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.78e-05	0.0012	CbGpPWpGaD
Betamethasone—Dyspepsia—Doxorubicin—uterine cancer	1.78e-05	0.000382	CcSEcCtD
Betamethasone—NR3C1—Gene Expression—SUZ12—uterine cancer	1.76e-05	0.00119	CbGpPWpGaD
Betamethasone—Decreased appetite—Doxorubicin—uterine cancer	1.76e-05	0.000377	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Doxorubicin—uterine cancer	1.75e-05	0.000375	CcSEcCtD
Betamethasone—Fatigue—Doxorubicin—uterine cancer	1.74e-05	0.000374	CcSEcCtD
Betamethasone—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	1.74e-05	0.00117	CbGpPWpGaD
Betamethasone—Urticaria—Epirubicin—uterine cancer	1.74e-05	0.000373	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	1.74e-05	0.00117	CbGpPWpGaD
Betamethasone—Pain—Doxorubicin—uterine cancer	1.73e-05	0.000371	CcSEcCtD
Betamethasone—Body temperature increased—Epirubicin—uterine cancer	1.73e-05	0.000371	CcSEcCtD
Betamethasone—Abdominal pain—Epirubicin—uterine cancer	1.73e-05	0.000371	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	1.72e-05	0.00116	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—CTNNB1—uterine cancer	1.71e-05	0.00116	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—EP300—uterine cancer	1.71e-05	0.00115	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—STK11—uterine cancer	1.7e-05	0.00114	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CYP19A1—uterine cancer	1.7e-05	0.00114	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—ESR1—uterine cancer	1.69e-05	0.00114	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	1.68e-05	0.00113	CbGpPWpGaD
Betamethasone—Feeling abnormal—Doxorubicin—uterine cancer	1.67e-05	0.000358	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—HRAS—uterine cancer	1.66e-05	0.00112	CbGpPWpGaD
Betamethasone—Gastrointestinal pain—Doxorubicin—uterine cancer	1.65e-05	0.000355	CcSEcCtD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—uterine cancer	1.65e-05	0.00111	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—SMAD3—uterine cancer	1.63e-05	0.0011	CbGpPWpGaD
Betamethasone—Urticaria—Doxorubicin—uterine cancer	1.61e-05	0.000345	CcSEcCtD
Betamethasone—NR3C1—Generic Transcription Pathway—ESR2—uterine cancer	1.61e-05	0.00108	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	1.6e-05	0.00108	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—EP300—uterine cancer	1.6e-05	0.00108	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—NRAS—uterine cancer	1.6e-05	0.00108	CbGpPWpGaD
Betamethasone—Body temperature increased—Doxorubicin—uterine cancer	1.6e-05	0.000343	CcSEcCtD
Betamethasone—Abdominal pain—Doxorubicin—uterine cancer	1.6e-05	0.000343	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—RNF43—uterine cancer	1.6e-05	0.00108	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.59e-05	0.00107	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	1.58e-05	0.00106	CbGpPWpGaD
Betamethasone—Asthenia—Epirubicin—uterine cancer	1.57e-05	0.000336	CcSEcCtD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.55e-05	0.00104	CbGpPWpGaD
Betamethasone—Pruritus—Epirubicin—uterine cancer	1.55e-05	0.000332	CcSEcCtD
Betamethasone—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	1.53e-05	0.00103	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CXCL8—uterine cancer	1.52e-05	0.00103	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.52e-05	0.00102	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.52e-05	0.00102	CbGpPWpGaD
Betamethasone—Diarrhoea—Epirubicin—uterine cancer	1.5e-05	0.000321	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.49e-05	0.001	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CXCL8—uterine cancer	1.49e-05	0.001	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CDKN1B—uterine cancer	1.48e-05	0.001	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	1.48e-05	0.000999	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	1.47e-05	0.000992	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—AKT1—uterine cancer	1.47e-05	0.000991	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—INHBA—uterine cancer	1.46e-05	0.000986	CbGpPWpGaD
Betamethasone—Asthenia—Doxorubicin—uterine cancer	1.45e-05	0.000311	CcSEcCtD
Betamethasone—Dizziness—Epirubicin—uterine cancer	1.45e-05	0.00031	CcSEcCtD
Betamethasone—PGR—Gene Expression—EZH2—uterine cancer	1.44e-05	0.000973	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	1.44e-05	0.000969	CbGpPWpGaD
Betamethasone—Pruritus—Doxorubicin—uterine cancer	1.43e-05	0.000307	CcSEcCtD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.42e-05	0.000959	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	1.42e-05	0.000955	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	1.41e-05	0.000954	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKR1B1—uterine cancer	1.41e-05	0.000949	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—STAR—uterine cancer	1.41e-05	0.000949	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.4e-05	0.000948	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	1.39e-05	0.00094	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	1.39e-05	0.000938	CbGpPWpGaD
Betamethasone—Vomiting—Epirubicin—uterine cancer	1.39e-05	0.000298	CcSEcCtD
Betamethasone—Diarrhoea—Doxorubicin—uterine cancer	1.38e-05	0.000297	CcSEcCtD
Betamethasone—Rash—Epirubicin—uterine cancer	1.38e-05	0.000296	CcSEcCtD
Betamethasone—PTGS2—C-MYB transcription factor network—KRAS—uterine cancer	1.38e-05	0.000929	CbGpPWpGaD
Betamethasone—Dermatitis—Epirubicin—uterine cancer	1.38e-05	0.000295	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—EP300—uterine cancer	1.38e-05	0.000928	CbGpPWpGaD
Betamethasone—Headache—Epirubicin—uterine cancer	1.37e-05	0.000294	CcSEcCtD
Betamethasone—Dizziness—Doxorubicin—uterine cancer	1.34e-05	0.000287	CcSEcCtD
Betamethasone—PGR—Gene Expression—ESR2—uterine cancer	1.34e-05	0.000902	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	1.34e-05	0.000902	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—ESR1—uterine cancer	1.33e-05	0.000898	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKR1C1—uterine cancer	1.32e-05	0.000888	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—CDKN2B—uterine cancer	1.31e-05	0.000882	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	1.3e-05	0.000879	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NDUFB11—uterine cancer	1.3e-05	0.000877	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SRD5A2—uterine cancer	1.3e-05	0.000877	CbGpPWpGaD
Betamethasone—Nausea—Epirubicin—uterine cancer	1.3e-05	0.000279	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.29e-05	0.00087	CbGpPWpGaD
Betamethasone—Vomiting—Doxorubicin—uterine cancer	1.29e-05	0.000276	CcSEcCtD
Betamethasone—Rash—Doxorubicin—uterine cancer	1.28e-05	0.000274	CcSEcCtD
Betamethasone—Dermatitis—Doxorubicin—uterine cancer	1.27e-05	0.000273	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—MTHFR—uterine cancer	1.27e-05	0.000859	CbGpPWpGaD
Betamethasone—Headache—Doxorubicin—uterine cancer	1.27e-05	0.000272	CcSEcCtD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.26e-05	0.000852	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKR1B10—uterine cancer	1.21e-05	0.000814	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—VEGFA—uterine cancer	1.21e-05	0.000814	CbGpPWpGaD
Betamethasone—Nausea—Doxorubicin—uterine cancer	1.2e-05	0.000258	CcSEcCtD
Betamethasone—NR3C1—Generic Transcription Pathway—SMAD3—uterine cancer	1.19e-05	0.000805	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.19e-05	0.000804	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	1.17e-05	0.00079	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.15e-05	0.000773	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.12e-05	0.000757	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—POLD1—uterine cancer	1.1e-05	0.000744	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.09e-05	0.000736	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—CDKN2B—uterine cancer	1.09e-05	0.000734	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.06e-05	0.000713	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.05e-05	0.00071	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.04e-05	0.000703	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKR1C1—uterine cancer	1.03e-05	0.000696	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKR1C3—uterine cancer	1.01e-05	0.000684	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.01e-05	0.000681	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RNF43—uterine cancer	1e-05	0.000675	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—SMAD3—uterine cancer	9.94e-06	0.000671	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—ESR1—uterine cancer	9.74e-06	0.000657	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	9.68e-06	0.000653	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	9.54e-06	0.000644	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—YWHAE—uterine cancer	9.43e-06	0.000636	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—STAR—uterine cancer	9.4e-06	0.000634	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKR1B1—uterine cancer	9.4e-06	0.000634	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—uterine cancer	9.33e-06	0.000629	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	9.3e-06	0.000627	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	9.29e-06	0.000627	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SRD5A2—uterine cancer	9.22e-06	0.000622	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NDUFB11—uterine cancer	9.22e-06	0.000622	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—RRM2—uterine cancer	9.2e-06	0.000621	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FBXW7—uterine cancer	9.04e-06	0.000609	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—DCN—uterine cancer	8.93e-06	0.000603	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	8.89e-06	0.0006	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	8.87e-06	0.000598	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PGR—uterine cancer	8.78e-06	0.000592	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP11A1—uterine cancer	8.42e-06	0.000568	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	8.4e-06	0.000567	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—EZH2—uterine cancer	8.34e-06	0.000563	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKR1C1—uterine cancer	8.24e-06	0.000556	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—ESR1—uterine cancer	8.11e-06	0.000547	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKR1C3—uterine cancer	7.95e-06	0.000536	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STK11—uterine cancer	7.9e-06	0.000533	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ESR2—uterine cancer	7.73e-06	0.000522	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	7.73e-06	0.000521	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SOCS3—uterine cancer	7.4e-06	0.000499	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—POLD1—uterine cancer	7.38e-06	0.000497	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	7.16e-06	0.000483	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	7.14e-06	0.000482	CbGpPWpGaD
Betamethasone—PTGS2—Disease—DCN—uterine cancer	7.13e-06	0.000481	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTEN—uterine cancer	7.09e-06	0.000478	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN2B—uterine cancer	7.08e-06	0.000478	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKR1C1—uterine cancer	6.9e-06	0.000465	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF1R—uterine cancer	6.88e-06	0.000464	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	6.77e-06	0.000456	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—EP300—uterine cancer	6.76e-06	0.000456	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKR1B1—uterine cancer	6.66e-06	0.000449	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—STAR—uterine cancer	6.66e-06	0.000449	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	6.59e-06	0.000445	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	6.56e-06	0.000443	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SMAD3—uterine cancer	6.46e-06	0.000436	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	6.35e-06	0.000428	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKR1C3—uterine cancer	6.34e-06	0.000428	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—CDKN2B—uterine cancer	6.29e-06	0.000425	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	6.29e-06	0.000424	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—STK11—uterine cancer	6.19e-06	0.000418	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HMGA1—uterine cancer	6.18e-06	0.000417	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGFR2—uterine cancer	6.17e-06	0.000416	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—RRM2—uterine cancer	6.15e-06	0.000415	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—DCN—uterine cancer	5.97e-06	0.000403	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	5.96e-06	0.000402	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.81e-06	0.000392	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SMAD3—uterine cancer	5.75e-06	0.000388	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SRD5A2—uterine cancer	5.68e-06	0.000383	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NDUFB11—uterine cancer	5.68e-06	0.000383	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FBXW7—uterine cancer	5.65e-06	0.000381	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP11A1—uterine cancer	5.62e-06	0.000379	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.54e-06	0.000374	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.36e-06	0.000362	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKR1C3—uterine cancer	5.31e-06	0.000358	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ESR1—uterine cancer	5.28e-06	0.000356	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—POLD1—uterine cancer	5.23e-06	0.000353	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	5.06e-06	0.000341	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CA—uterine cancer	5e-06	0.000337	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKR1C1—uterine cancer	4.89e-06	0.00033	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—uterine cancer	4.81e-06	0.000324	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ESR1—uterine cancer	4.69e-06	0.000316	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—MTHFR—uterine cancer	4.65e-06	0.000314	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	4.65e-06	0.000314	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCL2—uterine cancer	4.64e-06	0.000313	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	4.5e-06	0.000303	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN2B—uterine cancer	4.43e-06	0.000299	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—RRM2—uterine cancer	4.36e-06	0.000294	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—DCN—uterine cancer	4.23e-06	0.000285	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—STK11—uterine cancer	4.14e-06	0.000279	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP19A1—uterine cancer	4.14e-06	0.000279	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—STAR—uterine cancer	4.11e-06	0.000277	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKR1B1—uterine cancer	4.11e-06	0.000277	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.1e-06	0.000277	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—uterine cancer	4.09e-06	0.000276	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SMAD3—uterine cancer	4.04e-06	0.000273	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP11A1—uterine cancer	3.99e-06	0.000269	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.88e-06	0.000262	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ERBB2—uterine cancer	3.87e-06	0.000261	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGFR2—uterine cancer	3.86e-06	0.00026	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.8e-06	0.000256	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKR1C3—uterine cancer	3.76e-06	0.000254	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MTHFR—uterine cancer	3.71e-06	0.00025	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.7e-06	0.00025	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL8—uterine cancer	3.67e-06	0.000248	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN1B—uterine cancer	3.59e-06	0.000242	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CTNNB1—uterine cancer	3.39e-06	0.000228	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTEN—uterine cancer	3.3e-06	0.000223	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—POLD1—uterine cancer	3.22e-06	0.000217	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EP300—uterine cancer	3.15e-06	0.000212	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—MTHFR—uterine cancer	3.11e-06	0.00021	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKR1C1—uterine cancer	3.01e-06	0.000203	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—uterine cancer	2.98e-06	0.000201	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NRAS—uterine cancer	2.95e-06	0.000199	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—STK11—uterine cancer	2.93e-06	0.000198	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP19A1—uterine cancer	2.93e-06	0.000198	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—uterine cancer	2.93e-06	0.000197	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.74e-06	0.000185	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—RRM2—uterine cancer	2.69e-06	0.000181	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—DCN—uterine cancer	2.61e-06	0.000176	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTEN—uterine cancer	2.59e-06	0.000175	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KRAS—uterine cancer	2.54e-06	0.000171	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—EP300—uterine cancer	2.47e-06	0.000167	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.46e-06	0.000166	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERBB2—uterine cancer	2.42e-06	0.000163	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CA—uterine cancer	2.33e-06	0.000157	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.32e-06	0.000156	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—uterine cancer	2.25e-06	0.000152	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN1B—uterine cancer	2.24e-06	0.000151	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MTHFR—uterine cancer	2.2e-06	0.000149	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HRAS—uterine cancer	2.16e-06	0.000145	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CTNNB1—uterine cancer	2.12e-06	0.000143	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTEN—uterine cancer	2.07e-06	0.000139	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EP300—uterine cancer	1.97e-06	0.000133	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—uterine cancer	1.9e-06	0.000128	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NRAS—uterine cancer	1.84e-06	0.000124	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CA—uterine cancer	1.83e-06	0.000123	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.81e-06	0.000122	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—STK11—uterine cancer	1.81e-06	0.000122	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTEN—uterine cancer	1.73e-06	0.000117	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—uterine cancer	1.69e-06	0.000114	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—EP300—uterine cancer	1.65e-06	0.000111	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KRAS—uterine cancer	1.59e-06	0.000107	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—uterine cancer	1.49e-06	0.000101	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CA—uterine cancer	1.46e-06	9.83e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTHFR—uterine cancer	1.36e-06	9.16e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HRAS—uterine cancer	1.35e-06	9.09e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTEN—uterine cancer	1.23e-06	8.27e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CA—uterine cancer	1.22e-06	8.23e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—uterine cancer	1.19e-06	8.03e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—EP300—uterine cancer	1.17e-06	7.89e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—uterine cancer	9.97e-07	6.72e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CA—uterine cancer	8.65e-07	5.83e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTEN—uterine cancer	7.55e-07	5.1e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—EP300—uterine cancer	7.2e-07	4.86e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—uterine cancer	7.07e-07	4.77e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CA—uterine cancer	5.33e-07	3.59e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—uterine cancer	4.35e-07	2.94e-05	CbGpPWpGaD
